The AI company Anthropic is now worth $60 billion. The company’s cofounder and chief scientist, Jared Kaplan, shared how AI agents will develop in the coming year. ( MIT Technology Review)

To be honest, I was shocked at the outcome of the video, and even more so at the comments, all in agreement or saying things like “I rewrite what the AI says in my own words,” “What if I use Chat GPT to summarize the readings?

Companies will commonly split their stock after a strong run-up in price. While it doesn't change any of the underlying fundamentals of the company, it's a strong signal from management that it believes the stock will continue moving higher.

Preparing cancer patients for difficult decisions is an oncologist’s job. They don’t always remember to do it, however. At the University of Pennsylvania Health System, doctors are nudged to talk about a patient’s treatment and end-of-life preferences by an AI algorithm that predicts the chances of death.

A newly compiled dataset of nearly one billion images of auroras is helping researchers categorize—and perhaps ultimately anticipate—the Northern Lights.

Introduction - The year 2024 marked a pivotal time in artificial intelligence, where aspirations transformed into concrete achievements,

The industry's ability to establish effective governance hinges upon the ability to overcome the inherent challenges associated with using AI in healthcare.

The obvious answer would appear to be that the algorithm was likely trained on large tranches of Chinese data, and, thus, that data is influencing the algorithm’s output.

Stanford researchers built an algorithm to predict subtypes of Type 2 diabetes that works right from your home.

Technology can summon and reimagine the past through AI-generated videos based on algorithms that influence the content we consume.

The Biden Administration's new 'AI Diffusion' rule limits US-developed AI hardware and software reaching other countries, unless you're on the 'nice' list.

Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, clinical research,